My research focuses on the evaluation of the toxicity of nanomaterials and their ability to transport active anticancer drugs. I use various mouse models to study the nanoparticle's pharmacokinetics, excretion routes, biodistribution and long-term toxicity after intravenous administration. I am particularly interested in the impact of PEG-decorated nanoparticles on the immune response. For this purpose, I test the presence of anti-PEG antibodies and the presence of proinflammatory cytokines.